Solid tumours display elevated resistance to chemo-and radiotherapies compared to individual tumour derived cells. This so-called multicellular resistance (MCR) phenomenon can only be partly explained by reduced diffusion and altered cell cycle status; even fast growing cells on the surface of solid tumours display MCR. Multicellular spheroids (MCS) recapture this phenomenon ex vivo and here we compare gene expression in exponentially growing MCS with gene expression in monolayer culture. Using an 18,664 gene microarray, we identified 42 differentially expressed genes and three of these genes can be linked to potential mechanisms of MCR. A group of interferon response genes were also up-regulated in MCS, as were a number of genes that that are indicative of greater differentiation in three-dimensional cultures.
Introduction
Promising new anti-cancer agents identified using in vitro monolayer cultures of tumour derived cells often fail in vivo. Compared to mono-layer cell cultures, solid tumours are more resistant to anticancer therapies that directly target the malignant cell population. This phenomenon is known as multicellular resistance (MCR) (Desoize and Jardillier 2000) . MCR is also observed in MCS, which as a result have been heralded as an excellent in vitro model with which to study tumours and identify, test, and develop new therapies (Sutherland 1988; Mueller-Klieser 1997; Hamilton poor transport of drugs into the tumour, while reduced oxygen levels contribute to radio-resistance. Consideration of cell cycle status also explained some of the MCR effect, quiescent cells within the tumour/MCS being less susceptible to those agents targeting cellular proliferation. However, this cannot explain the observation that small MCS of only 25-50 cells, and cells from the outer layers of MCS, also exhibit a resistant phenotype (Olive and Durand 1994) . Furthermore, this resistance is retained for a period after dissociation of cells from the MCS (Olive et al. 1993; Olive and Durand 1994) . Such observations suggest that fundamental changes in the nature of cells growing as 3D tissue constructs must, at least in part, be responsible for the observed effects of MCR.
Compared to monolayers a variety of changes to cellular phenotype take place in 3D culture (e.g. changes to chromatin packing and cell size/shape (Olive and Durand 1994; Desoize and Jardillier 2000) , changes in sub-cellular protein localisation (Oloumi et al. 2000) , differential expression of adhesion molecules (Rainaldi et al. 1999; Shiras et al. 2002) , resistance to apoptosis (Desoize and Jardillier 2000) , increased expression of multidrug resistance related proteins (Wartenberg et al. 1998; Desoize and Jardillier 2000) and broader changes in protein expression (Poland et al. 2002) , and these in turn result in, or are the result of, altered gene expression (Olive and Durand 1994; Knowles and Phillips 2001; Oloumi et al. 2002) .
Only two investigations into broad changes in gene expression between monolayers and MCS have been undertaken (Knowles and Phillips 2001; Oloumi et al. 2002) , and these have identified a small number of differentially regulated genes. However, in consideration of the number of reports describing differential expression of specific genes and gene products, the true extent to which gene expression differs between MCS and monolayers is expected to be much greater.
We demonstrate that MCS generated from human colon carcinoma derived cells exhibit an MCR phenotype that cannot be easily explained by diffusion limitations and quiescent cell populations. These MCS differentially express 42 genes compared to monolayers, and based on known functions three of these can be linked with possible mechanisms of MCR. A number of interferon response and differentiation related genes are also differentially expressed, as are a group of genes that are also differentially expressed in tumours compared to healthy tissues.
Materials and methods

Monolayer cell culture
HCT116 colon carcinoma cells were routinely cultivated as monolayers in DMEM medium (GibcoBRL) supplemented with 10% foetal bovine serum (JRH Biosciences) in a 5% CO 2 , humidified atmosphere at 37°C. Cell enumeration was achieved using an improved Neubauer haemocytometer and trypan blue exclusion.
Multicellular spheroid culture
HCT116 MCS were cultivated by the hanging drop method as previously described (Kelm et al. 2003) . Twenty microlitres of single cell suspension were dispensed into the wells of a 60-well mini tray (Nunc), giving 100 cells/well. Trays were inverted, placed inside larger bio-assay trays, and incubated as above.
Analysis of multicellular spheroid growth kinetics
Images for kinetic analysis of MCS (n = 50) were captured at the desired times using an Olympus BX61 microscope fitted with a Cool-Snap cf Pro CCD camera (MediaCybernetics) and subsequently analysed for size and roundness (1 = perfectly round) using ImagePro Plus 4.5 (MediaCybernetics).
Sectioning and staining
MCS for histological sectioning were harvested on day 8 and fixed in 3.7% formaldehyde solution for 10 min. They were then rinsed with PBS and suspended in 30% sucrose solution (in PBS until) the MCS had sunk to the bottom of the tube, at which point OCT (TissueTek) was added and mixed, suspending the MCS in a 1:1 OCT: sucrose solution. This was then left overnight at room temperature. Samples were transferred to moulds, embedded in OCT, and stored at À80°C until sectioning. Frozen sections were obtained using a Leitz cryo-microtome, and transferred to SuperFrost Plus glass slides. Staining was achieved using Mayers hematoxylin (Sigma) and Eosin Y (Sigma).
Response to 5-fluorouracil exposure Day 8 (approximately 300 lm in diameter) MCS were harvested in PBS and transferred in approximately equal numbers to polystyrene dishes. To these MCS and T25 monolayer cultures, 100 lg/ ml 5-Fluorouracil (5FU) was added in fresh DMEM growth medium, and incubated as above.
At the desired times, monolayer cultures were trypsinised and resuspended in an appropriate volume of serum free DMEM. MCS were dissociated by incubation in 0.05% EDTA in PBS for 20 min at 37°C, followed by 5 min in 0.25% trypsin and aspiration with a 21 g needle. Cell viability for each sample was determined using a Molecular Probes Live/Dead assay kit. Sixty fields of a haemocytometer chamber were captured using the aforementioned microscopy system, and images were processed using ImagePro Plus 4.5 to identify the number of viable and non-viable cells in each. These data were then transferred to MS Excel and the % viability calculated.
Microarray profiling
The arrays used in this study were obtained from the SRC Microarray Facility, University of Queensland (ARC Centre for Functional and Applied Genomics), and comprised 18,664 (excluding controls) human gene-specific oligonucleotides (Compugen) spotted onto epoxy-silane coated sides (Eppendorf creative slides).
Total RNA was isolated from MCS (day 8) and monolayer cultures using a QIAGEN RNeasy purification kit. RNA quality and quantity were assessed using a Bioanalyser RNA6000 NanoAssay (Agilnet). Two micrograms of each total RNA sample were amplified using an Ambion Amino Allyl Messageamp TM aRNA Kit. Amplified RNA was labelled using indirect cy3/cy5 incorporation (Ambion). Hybridisations were performed in duplicate and incorporated a dye swap to account for dye bias. After 16 h hybridisation, the arrays were washed and scanned on an Agilnet 61565BA microarray scanner at a 5 lm resolution.
The resulting images were analysed using Imagene 5.5 (Biodiscovery) and the mean foreground, background and spot/signal quality determined. Data were then exported into Genespring 6.1 (Silicon Genetics) and the mean differential expression was observed. A further filtering of data with a mean intensity of at least 300 fluorescence units was included. Finally, elements with ‡ 2-fold change in expression between MCS and monolayers were identified.
Real-time PCR
Confirmation of differential gene expression for select genes was achieved through relative quantitation by real-time PCR using an Applied Biosystems ABI Prism 7000 sequence detection system and SYBR green (Applied Biosystems).
Total RNA was extracted from MCS and monolayer cultures as described above. RNA was DNase (Fermentas) treated, and cDNA generated by reverse transcription using Superscript III (Invitrogen) according to the manufacturers instructions. Primers were designed using Primer Express v2.0 (Applied Biosystems) and were purchased from Sigma Genosys (Table 1) .
Real-time PCR product identity was confirmed by melt curve analysis and 2% agarose gel Table 1 . Primers employed for real-time PCR.
Gene
Forward primer Reverse primer
electrophoresis. Absence of genomic DNA was confirmed in minus RT controls. No template controls were included in each run. Cycle thresholds were determined using ABI Prism 7000 SDS v1.1 software (Applied Biosystems) and efficiencies calculated by a log-linear fit to points either side of the threshold fluorescence value using LinReg v7.5 (Ramakers et al. 2003) . Data were normalised to GAPDH and the change in expression between MCS and monolayers was expressed as the ratio of these values. All data were collected in triplicate and errors calculated by propagation and expressed as the standard deviation in fold change.
Results
Growth characteristics of HCT116 multicellular spheroids (MCS)
HCT116 MCS cultivated by the hanging drop method display a typical Gompertz type growth pattern (Marusic et al. 1994; Lazareff et al. 1999; Kunz-Schughart and Mueller-Klieser 2000) , with an exponential increase in volume between days 3 and 9, followed by a decline in growth rate and subsequent plateau phase (Figure 1 ). This is parallelled by a decreasing roundness factor, indicating greater sphericity as cells coalesce and the MCS develops. MCS of approximately 300 lm diameter (day 8) showed no obvious signs of extensive central apoptosis or necrosis in histological sections (Figure 2 ).
Response to 5-fluorouracil exposure
Upon exposure to 100 lg/ml 5FU, MCS show reduced sensitivity compared to monolayer cell cultures. At 120 h, 58±1.9% of monolayer cells were no longer viable, compared to 31±1.6% of cells from MCS ( Figure 3 ). The method employed for viability counting circumvented issues of incomplete dissociation of MCS leading to small cell clusters. These clusters were a constant source of problems when using flow cytometric analysis, and further trypsination was considered overly harsh. Using image analysis it was possible to identify individual cells within small clusters. A slightly higher initial dead cell count for MCS most likely reflects membrane damage caused during dissociation. The use of MCS in the exponential phase (day 8) implies that if present, the quiescent cell population is small and does not represent a significant fraction of the total population, minimising the size of this resistant population.
Differential gene expression
Microarray profiling was used to identify genes differentially expressed in MCS compared to monolayers (Figure 4 ). Data revealed 42 transcripts Figure 1 . Growth kinetics of HCT116 MCS (volume -circle, roundness -square, n = 50). Cells aggregate and grow exponentially through to day 9, followed by a decline in growth rate and eventual plateau. Error bars depict standard error of the mean. differentially expressed by more than 2-fold (Table 2), three of these can be linked to potential mechanisms of MCR, 13 are involved in interferon response, 10 are differentiation related, and 14 are differentially regulated in tumours compared to healthy tissue. A further 17 differentially expressed genes were also identified. The use of MCS approximately 300 lm in diameter (exponential growth and absence of an apoptotic/necrotic core) should limit the extent of changes occurring in gene expression arising as a result of extreme environmental conditions (e.g. hypoxia response genes), changes in proliferate status (e.g. cell cycle regulators), and changes in cellular viability (e.g. apoptosis machinery), highlighting those genes differentially regulated in as a result of 3D architecture.
From a search of the available literature and gene databases, three genes were identified as candidate MCR related genes, and the differential expression of these genes (S100A4, SKIP3 and p48) verified by real-time PCR. Due to its position at the top of the interferon response signalling pathway and the high number of differentially regulated interferon response related genes identified, the differential expression of STAT1 was also verified by real-time PCR (Table 3) .
Discussion
Tumours and MCS exhibit enhanced resistance to anti-cancer agents compared to monolayer cultures (Nederman and Twentyman 1984; Mueller- . Scatter plot of average spot signal intensities from 18,664 gene microarrays. Outer diagonal lines represent a 2-fold change in signal intensity. Array hybridisations were performed in duplicate and incorporated a dye swap. Although shown above, spots with a signal intensity of less than 300 were excluded from further analysis. Table 2 . Genes differentially expressed by more than 2-fold (microarray) in HCT116 MCS compared to monolayers grouped by known function.
Gene name LocusLink Ontology
Expression ratio
MCR related
Interferon-stimulated transcription factor 3, gamma 48 kDa (p48) 10,379 Expression ratio is for MCS compared to monolayer (± standard deviation), gene ontology according to Compugen. Klieser 1997; Hamilton 1998; Kunz-Schughart et al. 1998; Dubessy et al. 2000; Fracasso and Colombatti 2000) , and this resistance cannot be fully explained by microenvironmental conditions or the existence of quiescent cell populations (Olive et al. 1993; Olive and Durand 1994; Desoize and Jardillier 2000) . When small (approximately 300 lm diameter) exponentially growing HCT116 colon carcinoma MCS (Figure 1 ) and monolayer cultures were continuously exposed to 5FU, a significant difference in cellular viability was observed after 120 h (31% vs. 58% respectively; Figure 3 ). As 5FU penetrates rapidly into MCS (Nederman and Twentyman 1984) , diffusion limitations cannot account for the reduced killing effect. Similarly, the use of MCS in the exponential growth phase excludes resistance arising from quiescent cell populations.
Changes in the expression of various genes and proteins are known to occur in 3D culture (Olive and Durand 1994; Knowles and Phillips 2001; Oloumi et al. 2002; Poland et al. 2002) and it is thought that these also contribute to the MCR phenotype. We employed microarray technology to examine the extent to which such changes in gene expression occur between the above cultures, and if these changes can be linked to possible mechanisms of MCR based on their known functions.
In total, we identified 42 genes differentially expressed by more than 2-fold in HCT116 MCS compared to monolayer cultures (Table 2) . Of these 42 genes, a review of available literature suggested that three of these might contribute to the MCR phenotype (S100A4, SKIP3, and p48), and the change in expression of these genes was evaluated by real-time PCR (Table 3) .
Up-regulation of S100A4 (calcium binding) in MCS has previously been identified at both the transcript and protein level (Oloumi et al. 2002) , and in tumours increased expression correlates with an invasive, metastatic phenotype (Rosty et al. 2002; Flatmark et al. 2003; Moriyama-Kita et al. 2004) . Oloumi et al. (2002) showed that S100A4 expression is up-regulated in V79 and C6 MCS, and that both are resistant to etoposide treatment. Hypothesising that this was due to differences in free intracellular calcium levels as a result of S100A4 activity, they treated monolayer cultures with the calcium chelating agent BAPTA-AM. When subsequently exposed to etoposide, monolayers treated with BAPTA-AM were found to be less sensitive to this drug, exhibiting decreased levels of DNA damage similar to that observed for MCS. We have also observed the upregulation of SI00A4 (2.3-fold) in HCT116 MCS, while others have identified the up-regulation of additional calcium binding proteins in other cell lines (Knowles and Phillips 2001; Oloumi et al. 2002; Poland et al. 2002) . The underlying reasons for the increased expression of calcium binding proteins remain unknown, but available data suggest that this may be a common feature of 3D cultures and might contribute to the MCR phenotype.
The second gene of relevance to the MCR, phenotype is SKIP3 (down-regulated 2.4-fold in MCS). SKIP3 is an NF-jB inducible gene, and a negative feed back inhibitor of NF-jB dependent gene expression (Wu et al. 2003 ) NF-jB is known to confer resistance to cytotoxic therapies via suppression of apoptosis, and its transcriptional activity is regulated by phosphorylation of the p65 subunit (Mayo and Baldwin 2000; Baldwin 2001; Weaver et al. 2002; Huang et al. 2003; Debatin 2004) . SKIP3 inhibits p65 phosphorylation by PKAc, reducing the transcriptional activity of NF-jB, and consequently sensitises cells to apoptosis (Wu et al. 2003) . A decrease in SKIP3 expression in HCT116 MCS might contribute to the MCR phenotype by reducing feedback inhibition of NF-jB, in turn conferring a degree of apoptosis suppression, NF-jB mediated apoptosis suppression might also contribute to the MCR phenotype of V79 MCS. Oloumi et al. (2002) observed the up-regulation of B-ind 1 in MCS cultures, the product of which potentiates activation of NF-jB via Rac1 (Courilleau et al. 2000) .
The third differentially regulated gene for which links to MCR can be drawn is p48. Up-regulated 4.4-fold in MCS, this interferon stimulated transcription factor is also involved in global genomic repair (Hwang et al. 1999; Luker et al. 2001) . Luker et al. (2001) demonstrated that overexpression of p48 in breast cancer derived cell lines imparts resistance to anti-microtubule agents. Several other IFN related genes were also up-regulated in paclitaxel resistant cells, and this resistant phenotype was independent of IFN signalling. Luker et al. (2001) conclude that p48 is responsible for the IFN independent regulation of downstream IFN-responsive genes, but were unable to identify the mechanism of p48 activation. They do however note that over-expression of IFN-inducible genes has been identified in confluent human mammary epithelial cells, but not proliferating cultures (Perou et al. 1999) . The simplest explanation for this observation is induction of down-stream IFN response genes by STAT1, which was also up-regulated (Perou et al. 1999) . In HCT116 MCS we also observe the up-regulation of STAT1 (1.8-fold by real-time PCR) and a group of 11 other IFN inducible genes, including p48.
While STAT1 is best recognised for its role in IFN signalling, the observations of Perou et al. (1999) and pattern of differential expression in tumours (Arany et al. 2003) , suggests a relationship to state of differentiation. Similarly, a number of the IFN related genes identified in our study are also indicators of differentiation, as are a number of genes for which expression varies in tumours. This is consistent with the widely held view that cells cultivated as MCS are more differentiated than those cultivated as monolayers.
In a more general sense, the identification of 42 differentially regulated genes demonstrates that the extent to which such changes occur in 3D culture is greater than previously reported, and that differential regulation of multiple genes in any given case may well contribute to the overall MCR phenotype. The three resistance related genes identified here, also suggest that different modes of resistance might exist for any given case, in this instance via modulation of intracellular calcium levels, apoptosis suppression, and enhanced DNA damage repair.
These findings relate specifically to the colon carcinoma cell line HCT116. Further microarray based studies using other cell lines may give a clearer understanding of common changes occurring in gene expression and/or reveal tumour-type related trends and additional MCR related genes.
Similarly functional studies directly examining the action of the identified genes (e.g. knockout/ RNAi) will firmly establish if they are indeed mediators of the MCR phenotype.
